The note, issued on February 25, 2025, was purchased by the Delaware limited partnership for $250,000. The note carries an annual interest rate of 6.0% and allows Channel Therapeutics the option to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback